Probiotic Lactobacillus casei strain and its uses
US-11813297-B2 · Nov 14, 2023 · US
This page is not indexed by search engines while we improve data quality.
Katholieke Univ Leuven Ku Leuven R & D — Human Necessities
Katholieke Univ Leuven Ku Leuven R & D holds 2 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Katholieke Univ Leuven Ku Leuven R & D |
| Technology | Human Necessities |
| Patents in slice | 2 |
| Recent patents in slice | 1 |
| First year | 2018 |
| Last year | 2023 |
Representative patents
Notable publications linking Katholieke Univ Leuven Ku Leuven R & D to Human Necessities.
Probiotic Lactobacillus casei strain and its uses
US-11813297-B2 · Nov 14, 2023 · US
Probiotic Lactobacillus casei strain and its uses
US-11813297-B2 · Nov 14, 2023 · US
Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders
US-9879058-B2 · Jan 30, 2018 · US
Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders
US-9879058-B2 · Jan 30, 2018 · US
Recent filings
Latest patents from Katholieke Univ Leuven Ku Leuven R & D in Human Necessities.
Probiotic Lactobacillus casei strain and its uses
US-11813297-B2 · Nov 14, 2023 · US
Probiotic Lactobacillus casei strain and its uses
US-11813297-B2 · Nov 14, 2023 · US
Probiotic Lactobacillus casei strain and its uses
US-11813297-B2 · Nov 14, 2023 · US
Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders
US-9879058-B2 · Jan 30, 2018 · US
Use of compounds that selectively modulate astrocytic release of substances through hemichannels of connexins and pannexins, without influencing gap junctions, for the treatment of psychiatric disorders
US-9879058-B2 · Jan 30, 2018 · US
Related pages
Navigate to parent entity pages.